share_log

Intelligent Bio Solutions | 8-K: Current report

Intelligent Bio Solutions | 8-K: Current report

Intelligent Bio Solutions | 8-K：重大事件
美股sec公告 ·  06/07 17:03
Moomoo AI 已提取核心信息
On June 6, 2024, Christopher Towers resigned from his position as a member of the Board of Directors and from his roles in the Audit Committee, the Compensation Committee, and the Nominating and Corporate Governance Committee at Intelligent Bio Solutions Inc., effective June 7, 2024. Towers, who was serving as the Chairman of the Audit Committee and the Nominating and Corporate Governance Committee, did not resign due to any disagreements with the company's operations, policies, or practices. Following his departure, Nicola Fraser was appointed to the Board and as the new Chair of the Audit Committee on June 7, 2024. Fraser, 48, is the Managing Partner of NextKey Services LLC and has a background in financial leadership roles at JP Morgan Chase, Fannie Mae, and Deloitte...Show More
On June 6, 2024, Christopher Towers resigned from his position as a member of the Board of Directors and from his roles in the Audit Committee, the Compensation Committee, and the Nominating and Corporate Governance Committee at Intelligent Bio Solutions Inc., effective June 7, 2024. Towers, who was serving as the Chairman of the Audit Committee and the Nominating and Corporate Governance Committee, did not resign due to any disagreements with the company's operations, policies, or practices. Following his departure, Nicola Fraser was appointed to the Board and as the new Chair of the Audit Committee on June 7, 2024. Fraser, 48, is the Managing Partner of NextKey Services LLC and has a background in financial leadership roles at JP Morgan Chase, Fannie Mae, and Deloitte. She is an active CPA and holds a CGMA designation. The Board has confirmed Fraser's independence according to Nasdaq rules. Additionally, Steven Boyages was appointed to the Compensation Committee and the Nominating and Corporate Governance Committee, also taking on the role of Chair for the latter. The Board's committee structure has been updated accordingly.
2024年6月6日，克里斯托弗 • 汤尔斯从智能生物解决方案公司的董事会成员及审计委员会、报酬委员会以及提名和企业治理委员会下台，生效日期为2024年6月7日。汤尔斯作为审计委员会和提名和企业治理委员会的主席，辞职时并未因公司的运营、政策或做法发生任何分歧。在他离开之后，尼古拉 • 弗雷泽于2024年6月7日被任命为董事会成员和审计委员会的新主席。48岁的弗雷泽是NextKey Services LLC的董事总经理，在JP摩根大通、法尼梅和德勤公司拥有金融领导角色背景。她是一位活跃的注册会计师，并持有CGMA资格证书。董事会已根据纳斯达克规定确认了弗雷泽的独立性。此外，史蒂芬 • 博亚杰斯被任命为报酬委员会和提名和企业治理委员会的成员，并担任后者的主席。董事会的委员会结构已经相应更新。
2024年6月6日，克里斯托弗 • 汤尔斯从智能生物解决方案公司的董事会成员及审计委员会、报酬委员会以及提名和企业治理委员会下台，生效日期为2024年6月7日。汤尔斯作为审计委员会和提名和企业治理委员会的主席，辞职时并未因公司的运营、政策或做法发生任何分歧。在他离开之后，尼古拉 • 弗雷泽于2024年6月7日被任命为董事会成员和审计委员会的新主席。48岁的弗雷泽是NextKey Services LLC的董事总经理，在JP摩根大通、法尼梅和德勤公司拥有金融领导角色背景。她是一位活跃的注册会计师，并持有CGMA资格证书。董事会已根据纳斯达克规定确认了弗雷泽的独立性。此外，史蒂芬 • 博亚杰斯被任命为报酬委员会和提名和企业治理委员会的成员，并担任后者的主席。董事会的委员会结构已经相应更新。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息